Previous 10 |
home / stock / pfscf / pfscf news
ProMetic Life Sciences ( OTCQX:PFSCF ): Q4 net loss of C$141.3M More news on: Prometic Life Sciences Inc., Earnings news and commentary, Tech stocks news, , Read more ...
Total revenues for 2018 of $47.4 million compared to $39.1 million in 2017 Significant increase in bioseparation 2018 revenues to $22.7 million , a 35% increase over 2017 Net loss of $ 237.9 million for the year ended December 31, 2018 includes a non-cash writedown of inta...
Prometic to Report its Fourth Quarter and 2018 Year-End Financial Results and Hold Conference Call / Webcast Canada NewsWire LAVAL, QC, March 26, 2019 LAVAL, QC , March 26, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Promet...
LAVAL, QC , March 25, 2019 /PRNewswire/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or the "Corporation") announced today that it has secured an additional USD $5 million (CAD $6.7 million ) tranche from Structured Alpha LP ("SALP"), an affiliate of T...
LAVAL, QC , Feb. 25, 2019 /PRNewswire/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or the "Corporation") announced today that it has secured an additional USD $10 million (CAD $13.2 million ) tranche from Structured Alpha LP ("SALP"), an affiliat...
Prometic retains investment bank for strategic transactions Canada NewsWire LAVAL, QC, Feb. 14, 2019 LAVAL, QC , Feb. 14, 2019 /CNW Telbec/ - Prometic Life Sciences Inc. (TSX: PLI), (OTCQX: PFSCF) ("Prometic" or the "Corporation") today announced that it has enga...
ProMetic Life Sciences ( OTCQX:PFSCF ) upgraded to Sector Perform at National Bank. More news on: ProMetic Life Sciences Inc., Selecta Biosciences, Nabriva Therapeutics, Healthcare stocks news, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Liminal Biosciences Inc - Ordinary Shares Company Name:
PFSCF Stock Symbol:
OTCMKTS Market:
Liminal Biosciences Inc - Ordinary Shares Website:
LAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, UK , Nov. 18, 2019 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biotechnology company focused on developing novel therapeutics to treat unmet needs ...
LAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, United Kingdom , Nov. 18, 2019 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biotechnology company focused on developing novel therapeutics to treat unmet needs in p...
Liminal BioSciences to Present at Stifel Healthcare Conference Canada NewsWire LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Nov. 15, 2019 LAVAL, QC , ROCKVILLE, MD and CAMBRIDGE, United Kingdom , Nov. 15, 2019 /CNW Telbec/ - Liminal BioSciences Inc. (TS...